Virtu Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-15,177
| Closed | -$531K | – | 2228 |
|
2021
Q2 | $531K | Buy |
+15,177
| New | +$531K | 0.05% | 445 |
|
2021
Q1 | – | Sell |
-6,074
| Closed | -$263K | – | 2247 |
|
2020
Q4 | $263K | Sell |
6,074
-242
| -4% | -$10.5K | 0.03% | 704 |
|
2020
Q3 | $348K | Sell |
6,316
-3,296
| -34% | -$182K | 0.06% | 385 |
|
2020
Q2 | $607K | Buy |
+9,612
| New | +$607K | 0.07% | 308 |
|
2019
Q4 | $441K | Sell |
5,548
-4,411
| -44% | -$351K | 0.04% | 476 |
|
2019
Q3 | $483K | Sell |
9,959
-7,247
| -42% | -$351K | 0.04% | 527 |
|
2019
Q2 | $905K | Buy |
17,206
+12,532
| +268% | +$659K | 0.05% | 309 |
|
2019
Q1 | $247K | Buy |
+4,674
| New | +$247K | 0.01% | 877 |
|
2018
Q4 | – | Sell |
-24,241
| Closed | -$921K | – | 2107 |
|
2018
Q3 | $921K | Buy |
24,241
+18,494
| +322% | +$703K | 0.06% | 355 |
|
2018
Q2 | $260K | Buy |
5,747
+615
| +12% | +$27.8K | 0.02% | 1263 |
|
2018
Q1 | $248K | Buy |
+5,132
| New | +$248K | 0.01% | 1197 |
|
2017
Q4 | – | Sell |
-11,450
| Closed | -$356K | – | 3196 |
|
2017
Q3 | $356K | Buy |
+11,450
| New | +$356K | 0.02% | 1220 |
|